BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹42 Cr | ₹36 Cr | ₹31 Cr | ₹25 Cr | ₹12 Cr |
What is the latest Profit After Tax of BETA DRUGS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹12 Cr |
How is Profit After Tax of BETA DRUGS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | 16.42 | |
| Mar2024 | ₹36 Cr | 18.61 | |
| Mar2023 | ₹31 Cr | 23.73 | |
| Mar2022 | ₹25 Cr | 111.75 | |
| Mar2021 | ₹12 Cr | - | |
Compare Profit After Tax of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,339.4 Cr | -6.7% | -21% | 13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -1.9% | -3.7% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 2.6% | 11.1% | 56% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | 0.2% | 1.3% | 38% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -1.5% | -6.4% | -12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -1% | -5.1% | -8.1% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -6.7% |
-21% |
13.5% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses